Cargando…
Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children
STUDY OBJECTIVE: In prehospital and emergency settings, vasoactive medications may need to be started through a peripheral intravenous catheter. Fear of extravasation and skin injury, with norepinephrine specifically, may prevent or delay peripheral vasopressor initiation, though studies from adults...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926000/ https://www.ncbi.nlm.nih.gov/pubmed/33718927 http://dx.doi.org/10.1002/emp2.12395 |
_version_ | 1783659374805254144 |
---|---|
author | Charbel, Ramy C. Ollier, Vincent Julliand, Sebastien Jourdain, Gilles Lode, Noëlla Tissieres, Pierre Morin, Luc |
author_facet | Charbel, Ramy C. Ollier, Vincent Julliand, Sebastien Jourdain, Gilles Lode, Noëlla Tissieres, Pierre Morin, Luc |
author_sort | Charbel, Ramy C. |
collection | PubMed |
description | STUDY OBJECTIVE: In prehospital and emergency settings, vasoactive medications may need to be started through a peripheral intravenous catheter. Fear of extravasation and skin injury, with norepinephrine specifically, may prevent or delay peripheral vasopressor initiation, though studies from adults suggest the actual risk is low. We sought to study the risk of extravasation and skin injury with peripheral administration of norepinephrine in children in the prehospital setting. METHODS: We performed a retrospective study of pediatric patients (≤18 years) who received a vasopressor during prehospital transport. We collected data from retrieval and hospital records from 2 pediatric medical retrieval teams in the Paris/Ile‐de‐France region. Patients were eligible if they had documentation of distributive or obstructive shock and administration of norepinephrine through a peripheral catheter (intravenous or intraosseous) during retrieval. The primary outcomes were the occurrence of extravasation and evidence of skin injury. We also examined approach to norepinephrine administration (concentration, duration, proximal vs distal site) and hospital outcomes. RESULTS: Over a 3‐year‐period, 37 pediatric patients received norepinephrine through a peripheral catheter (33 intravenous, 4 intraosseous). Median patient age was 1.8 years. Thirty‐two patients (86.5%) had septic shock. The median total duration of norepinephrine infusion was almost 4 hours. One patient (2.7%, 95% confidence interval 0.5%, 13.8%) had suspected extravasation from a 24‐gauge intravenous catheter in the hand, with local skin hypoperfusion. Skin changes were noted after 135 minutes of norepinephrine infusion. Perfusion normalized after catheter removal, and there were no other sequelae. CONCLUSIONS: In a 3‐year sample of pediatric patients from a large metropolitan area, we found only 1 patient with evidence of any harm with peripheral administration of norepinephrine. This finding is consistent with the adult literature but requires multicenter and multiyear investigation before a firm recommendation for this practice can be made. |
format | Online Article Text |
id | pubmed-7926000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79260002021-03-12 Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children Charbel, Ramy C. Ollier, Vincent Julliand, Sebastien Jourdain, Gilles Lode, Noëlla Tissieres, Pierre Morin, Luc J Am Coll Emerg Physicians Open Pediatrics STUDY OBJECTIVE: In prehospital and emergency settings, vasoactive medications may need to be started through a peripheral intravenous catheter. Fear of extravasation and skin injury, with norepinephrine specifically, may prevent or delay peripheral vasopressor initiation, though studies from adults suggest the actual risk is low. We sought to study the risk of extravasation and skin injury with peripheral administration of norepinephrine in children in the prehospital setting. METHODS: We performed a retrospective study of pediatric patients (≤18 years) who received a vasopressor during prehospital transport. We collected data from retrieval and hospital records from 2 pediatric medical retrieval teams in the Paris/Ile‐de‐France region. Patients were eligible if they had documentation of distributive or obstructive shock and administration of norepinephrine through a peripheral catheter (intravenous or intraosseous) during retrieval. The primary outcomes were the occurrence of extravasation and evidence of skin injury. We also examined approach to norepinephrine administration (concentration, duration, proximal vs distal site) and hospital outcomes. RESULTS: Over a 3‐year‐period, 37 pediatric patients received norepinephrine through a peripheral catheter (33 intravenous, 4 intraosseous). Median patient age was 1.8 years. Thirty‐two patients (86.5%) had septic shock. The median total duration of norepinephrine infusion was almost 4 hours. One patient (2.7%, 95% confidence interval 0.5%, 13.8%) had suspected extravasation from a 24‐gauge intravenous catheter in the hand, with local skin hypoperfusion. Skin changes were noted after 135 minutes of norepinephrine infusion. Perfusion normalized after catheter removal, and there were no other sequelae. CONCLUSIONS: In a 3‐year sample of pediatric patients from a large metropolitan area, we found only 1 patient with evidence of any harm with peripheral administration of norepinephrine. This finding is consistent with the adult literature but requires multicenter and multiyear investigation before a firm recommendation for this practice can be made. John Wiley and Sons Inc. 2021-03-02 /pmc/articles/PMC7926000/ /pubmed/33718927 http://dx.doi.org/10.1002/emp2.12395 Text en © 2021 The Authors. JACEP Open published by Wiley Periodicals LLC on behalf of American College of Emergency Physicians This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Pediatrics Charbel, Ramy C. Ollier, Vincent Julliand, Sebastien Jourdain, Gilles Lode, Noëlla Tissieres, Pierre Morin, Luc Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children |
title | Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children |
title_full | Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children |
title_fullStr | Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children |
title_full_unstemmed | Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children |
title_short | Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children |
title_sort | safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926000/ https://www.ncbi.nlm.nih.gov/pubmed/33718927 http://dx.doi.org/10.1002/emp2.12395 |
work_keys_str_mv | AT charbelramyc safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren AT olliervincent safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren AT julliandsebastien safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren AT jourdaingilles safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren AT lodenoella safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren AT tissierespierre safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren AT morinluc safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren |